PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
Gemcitabine + Cisplatin (GemCis) for Cancer: What Patients Need to Know. Learn how Gemcitabine + Cisplatin chemotherapy works, common side effects, evidence-based complementary therapies, and practical recovery strategies for cancer patients.
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies are the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage cancer is to combine the best of conventional and evidence-based non-conventional therapies.
I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.
Before beginning gemcitabine + cisplatin (GemCis) for cancer, consider:
Scroll down the page and post a question or a comment if there’s anything you’d like to know about carboplatin + paclitaxel for cancer.
Good luck,
David Emerson
Gemcitabine + Cisplatin (GemCis) for Cancer
If you’ve recently been diagnosed with bladder cancer, biliary tract cancer, non-small cell lung cancer, mesothelioma, cervical cancer, ovarian cancer, or pancreatic cancer, your oncologist may recommend Gemcitabine + Cisplatin, often shortened to GemCis or GC.
This combination has become one of the world’s most commonly used platinum-based chemotherapy regimens because it combines two drugs that attack cancer cells in different ways while producing better response rates than either drug alone.
Although GemCis is effective, it can also produce predictable side effects—many of which can be reduced through proactive supportive care, nutrition, exercise, and evidence-based complementary therapies.
As a cancer survivor myself, I’ve learned that preparing before side effects occur is often the best way to stay healthier throughout treatment.
GemCis combines:
Gemcitabine (Gemzar®)
Cisplatin (Platinol®)
Because they attack cancer differently, the combination is more effective than either drug alone.
GemCis is commonly used for:
Although schedules vary by cancer type, a common regimen is:
Day 1
Day 8
Days 9–21
Recovery period
Then the cycle repeats every 21 days, usually for 4–6 cycles, depending on the cancer type and treatment goals.
| Side Effect | Frequency | Usually Temporary? |
|---|---|---|
| Fatigue | Very common | Usually |
| Nausea/Vomiting | Very common | Yes |
| Low white blood cells | Very common | Yes |
| Low platelets | Common | Yes |
| Anemia | Common | Often |
| Kidney injury | Common | Sometimes |
| Hearing loss | Less common | May be permanent |
| Peripheral neuropathy | Common | May persist |
| Constipation | Common | Yes |
| Appetite loss | Common | Yes |
| Electrolyte abnormalities | Common | Usually |
This is the side effect that oncologists monitor most carefully.
Cisplatin can damage the kidneys because it accumulates in kidney tubule cells.
Your oncology team typically protects the kidneys by:
Cisplatin commonly damages peripheral nerves.
Symptoms include:
Neuropathy can continue worsening for months after chemotherapy ends (“coasting”).
Evidence-based supportive therapies include:
Cisplatin can damage the tiny hair cells inside the inner ear.
Symptoms include:
Patients noticing hearing changes should notify their oncologist promptly. Dose adjustments or alternative platinum drugs may sometimes be considered.
Cancer-related fatigue results from multiple factors:
One of the strongest evidence-based treatments is regular moderate exercise, even during chemotherapy.
Gemcitabine suppresses bone marrow.
Possible consequences include:
Helpful strategies include:
| Therapy | Side Effect | Evidence | Comments |
|---|---|---|---|
| Exercise | Fatigue | ★★★★★ | Strongest evidence |
| Acupuncture | Nausea, neuropathy | ★★★★☆ | Good supportive evidence |
| Ginger | Nausea | ★★★★☆ | Helpful with antiemetics |
| Meditation | Anxiety | ★★★★★ | Excellent evidence |
| Protein-rich diet | Recovery | ★★★★☆ | Supports healing |
| Hydration | Kidney protection | ★★★★★ | Critical with cisplatin |
| Sleep optimization | Fatigue | ★★★★☆ | Improves resilience |
| Cryotherapy | Neuropathy | ★★★☆☆ | Emerging evidence |
| Magnesium (if deficient) | Cisplatin-associated electrolyte loss | ★★★★☆ | Replace under medical supervision |
Many patients tolerate GemCis better by:
| Intervention | Evidence |
|---|---|
| Exercise | ★★★★★ |
| Modern anti-nausea medications | ★★★★★ |
| Hydration protocols | ★★★★★ |
| Acupuncture | ★★★★☆ |
| Ginger | ★★★★☆ |
| Sleep optimization | ★★★★☆ |
| Protein nutrition | ★★★★☆ |
| Cryotherapy | ★★★☆☆ |
| Alpha-lipoic acid | ★★☆☆☆ (mixed evidence) |
Seminal Trials
Supportive Care
4. ASCO Guidelines: Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy.
5. ASCO Guidelines: Exercise During Cancer Treatment.
6. ASCO Guidelines: Cancer-Related Fatigue.
7. MASCC/ESMO Antiemetic Guidelines.
8. KDIGO Clinical Practice Guideline for Acute Kidney Injury.
9. Cochrane Review: Acupuncture for chemotherapy-induced nausea and vomiting.
10. National Cancer Institute. Gemcitabine-Cisplatin regimen overview.